Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Load latest

Emcure Pharmaceuticals Ltd.

22 May 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Appointment Of Secretarial Auditor

BSE India

Appointment of M/s. SVD & Associates, Company Secretaries in Practice, as the Secretarial Auditors of the Company, for a term of 5 (five) consecutive years commencing from financial year 2025-26, subject to approval by the Members at the ensuing Annual General Meeting of the Company.

pdf

Emcure Pharmaceuticals Ltd.

22 May 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company.

pdf

Emcure Pharmaceuticals Ltd.

22 May 2025

1322.50

-2.00%

Result

Emcure Pharmaceuticals Ltd - 544210 - Audited Financial Results For The Quarter And Year Ended March …

BSE India

Audited Financial Results for the quarter and year ended March 31, 2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	2120.70	1966.53	1783.10	7.8%	18.9%
Operating Profit Qtr	402.40	354.61	311.35	13.5%	29.2%
Net Profit Qtr	188.96	153.72	115.17	22.9%	64.1%
Earning Per Share Adjusted latest Qtr	9.97	8.11	6.08	22.9%	64.0%

* Consolidated data

Detailed Results

Emcure Pharmaceuticals Ltd.

22 May 2025

1322.50

-2.00%

Corp. Action

Emcure Pharmaceuticals Ltd - 544210 - Corporate Action-Board approves Dividend

BSE India

Recommendation of Final Dividend for the financial year 2024-25

pdf

Emcure Pharmaceuticals Ltd.

22 May 2025

1322.50

-2.00%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on May 22, 2025: 1. Audited Financial Results (standalone and consolidated) for the quarter and year ended March 31, 2025. 2. Dividend 3. Re-appointment of Dr. Mukund Gurjar (DIN: 00026843) as a Whole-time Director of the Company 4. Appointment of Secretarial Auditors of the Company 5. Incorporation of a wholly-owned Subsidiary by the name 'Emcure Generics Private Limited' in Pune, Maharashtra, India

pdf

Emcure Pharmaceuticals Ltd.

13 May 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday, May 22, 2025 at 3:30 p.m. (IST) to discuss the Audited Financial Results (standalone and consolidated) and performance for the quarter and year ended March 31, 2025.

pdf

Emcure Pharmaceuticals Ltd.

13 May 2025

1322.50

-2.00%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone …

BSE India

Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2025 and recommendation of Final Dividend, if any.

pdf

Emcure Pharmaceuticals Ltd.

18 Apr 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") - Update on USFDA inspection at API manufacturing facility located at Kurkumbh, Pune, Maharashtra, India

pdf

Emcure Pharmaceuticals Ltd.

18 Apr 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Of Change In Email And Website Address Of Registrar …

BSE India

Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company

pdf

Emcure Pharmaceuticals Ltd.

08 Apr 2025

1322.50

-2.00%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025, received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company.